Skip to main content
Top
Published in: Diabetologia 10/2014

01-10-2014 | Article

Fracture risk in diabetic elderly men: the MrOS study

Authors: Nicola Napoli, Elsa S. Strotmeyer, Kristine E. Ensrud, Deborah E. Sellmeyer, Douglas C. Bauer, Andrew R. Hoffman, Thuy-Tien L. Dam, Elizabeth Barrett-Connor, Lisa Palermo, Eric S. Orwoll, Steven R. Cummings, Dennis M. Black, Ann V. Schwartz

Published in: Diabetologia | Issue 10/2014

Login to get access

Abstract

Aims/hypothesis

Diabetes mellitus is associated with increased fracture risk in women but few studies are available in men. To evaluate the relationship between diabetes and prospective non-vertebral fractures in elderly men, we used data from the Osteoporotic Fractures in Men (MrOS) study.

Methods

The MrOS enrolled 5,994 men (aged ≥65 years). Diabetes (ascertained by self-report, the use of medication for diabetes or an elevated fasting glucose level) was reported in 881 individuals, 80 of whom were using insulin. Hip and spine bone mineral density (BMD) was measured using dual x-ray absorptiometry (DXA). After recruitment, the men were followed for incident non-vertebral fractures using a triannual (3 yearly) questionnaire for an average of 9.1 (SD 2.7) years. The Cox proportional hazards model was used to assess the incident risk of fractures.

Results

In models adjusted for age, race, clinic site and total hip BMD, the risk of non-vertebral fracture was higher in men with diabetes compared with normoglycaemic men (HR 1.30, 95% CI 1.09, 1.54) and was elevated in men using insulin (HR 2.46, 95% CI 1.69, 3.59). Men with impaired fasting glucose did not have a higher risk of fracture compared with normoglycaemic men (HR 1.04, 95% CI 0.89, 1.21). After multivariable adjustment, the risk of non-vertebral fracture remained higher only among men with diabetes who were using insulin (HR 1.74, 95% CI 1.13, 2.69).

Conclusions/interpretation

Men with diabetes who are using insulin have an increased risk of non-vertebral fracture for a given age and BMD.
Literature
1.
go back to reference Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38PubMedCrossRef Schwartz AV, Sellmeyer DE, Ensrud KE et al (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86:32–38PubMedCrossRef
2.
go back to reference Bonds DE, Larson JC, Schwartz AV et al (2006) Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404–3410PubMedCrossRef Bonds DE, Larson JC, Schwartz AV et al (2006) Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404–3410PubMedCrossRef
3.
go back to reference Nicodemus KK, Folsom AR (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192–1197PubMedCrossRef Nicodemus KK, Folsom AR (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24:1192–1197PubMedCrossRef
4.
go back to reference Janghorbani M, van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef Janghorbani M, van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef
5.
go back to reference Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef
7.
go back to reference Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H (2006) Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:495–500PubMedCrossRef Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Schirmer H (2006) Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study. Osteoporos Int 17:495–500PubMedCrossRef
8.
go back to reference de Liefde I, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720PubMedCrossRef de Liefde I, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16:1713–1720PubMedCrossRef
9.
go back to reference Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:1065–1077PubMedCrossRef Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Akesson K (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:1065–1077PubMedCrossRef
10.
go back to reference Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S (2008) Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23:1334–1342PubMedCentralPubMedCrossRef Melton LJ 3rd, Leibson CL, Achenbach SJ, Therneau TM, Khosla S (2008) Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23:1334–1342PubMedCentralPubMedCrossRef
11.
go back to reference Blank JB, Cawthon PM, Carrion-Petersen ML et al (2005) Overview of recruitment for the Osteoporotic Fractures in Men study (MrOS). Contemp Clin Trials 26:557–568PubMedCrossRef Blank JB, Cawthon PM, Carrion-Petersen ML et al (2005) Overview of recruitment for the Osteoporotic Fractures in Men study (MrOS). Contemp Clin Trials 26:557–568PubMedCrossRef
12.
go back to reference Orwoll E, Blank JB, Barrett-Connor E et al (2005) Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study – a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26:569–585PubMedCrossRef Orwoll E, Blank JB, Barrett-Connor E et al (2005) Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study – a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26:569–585PubMedCrossRef
13.
go back to reference American Diabetes Association (2012) Standards of medical care in diabetes – 2012. Diabetes Care 35(Suppl 1):S11–S63 American Diabetes Association (2012) Standards of medical care in diabetes – 2012. Diabetes Care 35(Suppl 1):S11–S63
14.
go back to reference Lewis CE, Ewing SK, Taylor BC et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22:211–219PubMedCrossRef Lewis CE, Ewing SK, Taylor BC et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22:211–219PubMedCrossRef
15.
go back to reference Mackey DC, Lui LY, Cawthon PM et al (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298:2381–2388PubMedCrossRef Mackey DC, Lui LY, Cawthon PM et al (2007) High-trauma fractures and low bone mineral density in older women and men. JAMA 298:2381–2388PubMedCrossRef
16.
go back to reference Sanders KM, Pasco JA, Ugoni AM et al (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13:1337–1342PubMedCrossRef Sanders KM, Pasco JA, Ugoni AM et al (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13:1337–1342PubMedCrossRef
17.
go back to reference Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162PubMedCrossRef Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162PubMedCrossRef
18.
go back to reference Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10:405–411PubMedCrossRef Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10:405–411PubMedCrossRef
19.
go back to reference Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48:314–318PubMed Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48:314–318PubMed
20.
go back to reference Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol 56:M146–M156CrossRef Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol 56:M146–M156CrossRef
21.
go back to reference Ensrud KE, Ewing SK, Cawthon PM et al (2009) A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 57:492–498PubMedCentralPubMedCrossRef Ensrud KE, Ewing SK, Cawthon PM et al (2009) A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 57:492–498PubMedCentralPubMedCrossRef
22.
go back to reference Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3rd (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363–369PubMedCrossRef Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3rd (1987) Psychotropic drug use and the risk of hip fracture. N Engl J Med 316:363–369PubMedCrossRef
24.
go back to reference Schwartz AV, Vittinghoff E, Bauer DC et al (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192PubMedCentralPubMedCrossRef Schwartz AV, Vittinghoff E, Bauer DC et al (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192PubMedCentralPubMedCrossRef
25.
go back to reference De Rekeneire N, Resnick HE, Schwartz AV et al (2003) Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care 26:3257–3263PubMedCrossRef De Rekeneire N, Resnick HE, Schwartz AV et al (2003) Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care 26:3257–3263PubMedCrossRef
26.
go back to reference Barzilay JI, Cotsonis GA, Walston J et al (2009) Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged > or =70 years. Diabetes Care 32:736–738PubMedCentralPubMedCrossRef Barzilay JI, Cotsonis GA, Walston J et al (2009) Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged > or =70 years. Diabetes Care 32:736–738PubMedCentralPubMedCrossRef
27.
go back to reference Schafer AL, Vittinghoff E, Lang TF et al (2010) Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab 95:E368–E372PubMedCentralPubMedCrossRef Schafer AL, Vittinghoff E, Lang TF et al (2010) Fat infiltration of muscle, diabetes, and clinical fracture risk in older adults. J Clin Endocrinol Metab 95:E368–E372PubMedCentralPubMedCrossRef
28.
go back to reference Bazelier MT, Gallagher AM, van Staa TP et al (2012) Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiol Drug Saf 21:507–514PubMedCrossRef Bazelier MT, Gallagher AM, van Staa TP et al (2012) Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiol Drug Saf 21:507–514PubMedCrossRef
29.
go back to reference Monami M, Cresci B, Colombini A et al (2008) Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 31:199–203PubMedCrossRef Monami M, Cresci B, Colombini A et al (2008) Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 31:199–203PubMedCrossRef
30.
go back to reference Huang S, Kaw M, Harris MT et al (2010) Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 46:1138–1145PubMedCentralPubMedCrossRef Huang S, Kaw M, Harris MT et al (2010) Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 46:1138–1145PubMedCentralPubMedCrossRef
31.
go back to reference Petit MA, Paudel ML, Taylor BC et al (2010) Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 25:285–291PubMedCentralPubMedCrossRef Petit MA, Paudel ML, Taylor BC et al (2010) Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J Bone Miner Res 25:285–291PubMedCentralPubMedCrossRef
32.
go back to reference Yamaguchi T, Sugimoto T (2011) Bone metabolism and fracture risk in type 2 diabetes mellitus. Endocr J 58:613–624 (Review)PubMedCrossRef Yamaguchi T, Sugimoto T (2011) Bone metabolism and fracture risk in type 2 diabetes mellitus. Endocr J 58:613–624 (Review)PubMedCrossRef
33.
go back to reference Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94:2380–2386PubMedCentralPubMedCrossRef Schwartz AV, Garnero P, Hillier TA et al (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94:2380–2386PubMedCentralPubMedCrossRef
34.
go back to reference Ivers RQ, Cumming RG, Mitchell P, Peduto AJ, Blue Mountains Eye Study (2001) Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24:1198–1203PubMedCrossRef Ivers RQ, Cumming RG, Mitchell P, Peduto AJ, Blue Mountains Eye Study (2001) Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24:1198–1203PubMedCrossRef
35.
go back to reference Cefalu CA, Cefalu WT (2005) Controlling hypoglycemia in type 2 diabetes: which agent for which patient? J Fam Pract 54:855–862PubMed Cefalu CA, Cefalu WT (2005) Controlling hypoglycemia in type 2 diabetes: which agent for which patient? J Fam Pract 54:855–862PubMed
36.
go back to reference Kahn SE, Zinman B, Lachin JM et al (2008) Rosiglitazone associated fractures in type 2 diabetes: an analysis from ADOPT. Diabetes Care 31:845–851PubMedCrossRef Kahn SE, Zinman B, Lachin JM et al (2008) Rosiglitazone associated fractures in type 2 diabetes: an analysis from ADOPT. Diabetes Care 31:845–851PubMedCrossRef
37.
go back to reference Schneider AL, Pankow JS, Heiss G, Selvin E (2012) Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiol 176:738–743PubMedCentralPubMedCrossRef Schneider AL, Pankow JS, Heiss G, Selvin E (2012) Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study. Am J Epidemiol 176:738–743PubMedCentralPubMedCrossRef
38.
go back to reference Margolis KL, Lihong Q, Brzyski R et al (2008) Women Health Initiative Investigators. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5:240–247PubMedCentralPubMedCrossRef Margolis KL, Lihong Q, Brzyski R et al (2008) Women Health Initiative Investigators. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5:240–247PubMedCentralPubMedCrossRef
39.
go back to reference Sun JK, Keenan HA, Cavallerano JD et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-year medalist study. Diabetes Care 34:968–974PubMedCentralPubMedCrossRef Sun JK, Keenan HA, Cavallerano JD et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-year medalist study. Diabetes Care 34:968–974PubMedCentralPubMedCrossRef
40.
go back to reference Bain SC, Gill GV, Dyer PH, Jones AF et al (2003) Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 20:808–811PubMedCrossRef Bain SC, Gill GV, Dyer PH, Jones AF et al (2003) Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 20:808–811PubMedCrossRef
41.
go back to reference Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765PubMedCrossRef Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765PubMedCrossRef
Metadata
Title
Fracture risk in diabetic elderly men: the MrOS study
Authors
Nicola Napoli
Elsa S. Strotmeyer
Kristine E. Ensrud
Deborah E. Sellmeyer
Douglas C. Bauer
Andrew R. Hoffman
Thuy-Tien L. Dam
Elizabeth Barrett-Connor
Lisa Palermo
Eric S. Orwoll
Steven R. Cummings
Dennis M. Black
Ann V. Schwartz
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3289-6

Other articles of this Issue 10/2014

Diabetologia 10/2014 Go to the issue